A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes.

David Tak Wai Lui Tingting Wu Ivan Chi Ho Au Xiaodong LiuMatrix Man Him FungChi Ho LeeCarol Ho Yi FongYu Cho WooBrian Hung-Hin Lang Kathryn Choon Beng Tan Carlos King-Ho Wong

Published in: Drug safety (2022)

Preoperative SGLT2i use was associated with increased risks of postoperative DKA in patients with type 2 diabetes. Clinicians could optimize patients' outcomes by appropriate prescription of SGLT2i, while watching out for high-risk features. Implementing automatic electronic health record pop-up alerts may reduce the risk of SGLT2i-associated postoperative DKA.

Keyphrases

patients undergoing
electronic health record
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
type diabetes
machine learning
deep learning
metabolic syndrome
patient reported outcomes
climate change
human health